Soft tissue ablation procedures are set to see significant advancements with the Food and Drug Administration (FDA) granting 510(k) clearance for Varian’s IntelliBlate microwave ablation system. The system is engineered to offer clinicians increased predictability, precision, and control during ablation procedures. It creates large, controlled spherical ablation zones, ensuring predictable treatment outcomes.
The IntelliBlate system’s design emphasizes flexibility and precision, featuring dual probe capability with each probe offering linked or independent controls to cater to individual patient needs. The Ximitry probe enhances precision with advanced features such as LED indicators and laser disk alignment.
Varian Interventional Solutions vice-president and chief medical officer Dr. David Hahn stated, “IntelliBlate combines the features our customers say are most important for an efficient, integrated solution to seek improved levels of performance in microwave ablation. This innovative system brings new versatility in treatment options, fueling clinician-driven innovation to tackle a wide variety of cases. Real-time monitoring and treatment information at the tissue level aim to further empower care teams with the confidence to deliver highly personalized care to patients.”
In partnership with Siemens Healthineers, Varian continues to invest in the development of integrated microwave ablation technologies that combine therapy and image-guided solutions. This collaboration aims to enhance the precision and effectiveness of ablation procedures, offering clinicians tools to improve patient outcomes.
The IntelliBlate system’s ability to create large, controlled spherical ablation zones is a significant advancement in soft tissue ablation, ensuring predictable and effective treatment outcomes. The system’s dual probe capability allows for tailored treatment approaches, accommodating individual patient needs with linked or independent probe controls. The Ximitry probe’s advanced features, such as LED indicators and laser disk alignment, further enhance the precision of the IntelliBlate system. These features provide clinicians with real-time feedback and precise control during ablation procedures, improving the accuracy and effectiveness of treatments.
Soft Tissue Ablation: Varian Integrates Intelligent Therapeutic Technologies
Varian’s commitment to integrating intelligent therapeutic technologies and image-guided innovations into a unified platform reflects the company’s dedication to advancing the field of soft tissue ablation. This integration aims to offer clinicians enhanced predictability in probe placement, treatment delivery, and procedural confirmation, ultimately improving patient outcomes. Dr. David Hahn highlighted the significance of IntelliBlate in addressing the needs of clinicians and patients. The system’s ability to deliver real-time monitoring and treatment information at the tissue level empowers care teams to provide highly personalized care. This level of precision and control is essential for achieving optimal treatment outcomes in a wide variety of cases.
The collaboration between Varian and Siemens Healthineers underscores the importance of combining therapy and image-guided solutions to enhance the precision and effectiveness of ablation procedures. This partnership aims to develop integrated microwave ablation technologies that offer clinicians the tools they need to improve patient outcomes and deliver personalized care.
As Varian continues to innovate and develop advanced technologies, the IntelliBlate system stands out as a significant advancement in the field of soft tissue ablation. The system’s design, features, and capabilities position it as a valuable tool for clinicians seeking to provide effective and personalized care to their patients. The FDA clearance of the IntelliBlate system marks a significant milestone for Varian and the field of soft tissue ablation. This innovative system offers clinicians increased predictability, precision, and control during ablation procedures, ultimately improving patient outcomes and advancing the field of soft tissue ablation.
Resource: Varian, July 29, 2024
This article has been prepared with the assistance of AI and reviewed by an editor. For more details, please refer to our Terms and Conditions. We do not accept any responsibility or liability for the accuracy, content, images, videos, licenses, completeness, legality, or reliability of the information contained in this article. If you have any complaints or copyright issues related to this article, kindly contact the author.
